Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian Cohort @cancer-control.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #carcinoma #biomarkers #oncology #prognosis

📢 The NPCA State of the Nation Report 2025 is OUT! Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca... @natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social Please share!

🗣️ New #ESTROWebinar! Management of SCLC in the Immunotherapy Era 🗓 5 Nov | 17:00–18:00 CET Chaired by Prof Corinne Faivre-Finn & Dr Suraiya Dubash (UK) 💻 Live Q&A with experts! More info & Registration here: 👉 bit.ly/3KAbjPB #RadiationOncology #LungCancer #SCLC #Immunotherapy #Webinar

📢 The first-ever ESTRO Clinical Workshop is coming to Vienna | 12–13 Mar 2026! Spots are limited—don’t miss out. 📌 Submit your motivational statement by 22 Oct to secure your place. 💻 Apply now 👉 bit.ly/47wlj5G #ESTROCLIN26 #ClinicalWorkshop #RadiationOncology

💡 Discover the latest in mutation-driven lung cancer research. Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together. 📅 13 Nov | 📍 The View, London 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer

Calling all Young and Early Career Cancer Nurses (YECCN) The YECCN MIG is currently looking for 1x MIG Chair, 1x secretary and 8x committee members. If interested & under 35/working for <5yrs, please email by 5th October, a 300 word expression of interest to: [email protected] #YECCN

Exciting news! We’ve launched ASCO Edge, an online oncology practice management educational series exclusively available to ASCO members. Get started today: brnw.ch/21wVVu3

Please check out this from We Own It. weownit.org.uk/act-now/new-...

Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC @drewmoghanaki.bsky.social @gerryhanna.bsky.social oncodaily.com/voices/drew-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCLC #LungCancer

Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the #radiotherapy delineation benchmark case procedure, published in the Green Journal. 👉 Read it before your patients: bit.ly/4fLoatJ

New #radiotherapy innovations are being stifled by the tortuous commissioning process. Patients deserve better! #radonc #oncology #medtwitter Postcode lottery for new cancer treatments, doctors warn - BBC News www.bbc.co.uk/news/article...

📢 Attending #EAPM2025 this week? Today, our @eortc.org #QualityofLife Group member Ines Rathgeber will report on the development of an e-learning course focusing on the use of EORTC PRO measures for quality of life assessment in clinical practice 👇 eapm.eu.com/2025-eapm-co... #CancerResearch

✅ Finished treatment or on maintenance for #PancreaticCancer? We’ve got resources to help. Find tips on managing side effects, eating well, coping with scanxiety, and staying up to date on the latest research. https://bit.ly/4lX0owd #GuideToAction #LetsWinPC

One Voice for Radiotherapy: Creating World Radiotherapy Awareness Day oncodaily.com/insight/one-... #Cancer #Oncology #OncoDaily #Health #Medicine

Putting Patients First: Transforming Cancer Diagnosis, Treatment and Care Through Patient-Centred Approaches. In this guest editorial, we reflect on why meaningful progress & the delivery of high quality cancer care requires more than technical innovation www.radiographyonline.com/article/S107...

Today on #WorldLungCancerDay, we reaffirm our mission to support thoracic oncology professionals and advocate for equitable, world-class care for all patients. Together, we strive to match the best survival rates globally. 💙 #WLCD2025 #LungCancerAwareness #LCSM #lungcancer

🧠 Why does glioblastoma always outsmart treatment? In our #Neuro-Oncology paper, we identified proneural-mesenchymal hybrid glioblastoma cells that are resistant to therapy and dependent on nuclear import. doi.org/10.1093/neuo... Short walkthrough below. Let’s dive in! 🧵 (1/9) #GBM, #BrainTumor

BREAKING NEWS Scientists at the @icr-ctsu.bsky.social have discovered how to predict which ER+ HER2+ cancers have a higher risk of recurrence in just 2 weeks! Breaking news - Breast Cancer Breakthrough! #breastcancer youtube.com/shorts/3rYUU...

important listen for all involved in #radiotherapy. pca.st/episode/a767...

✨Today is #BrachytherapyAwarenessDay, let's spotlight precision in cancer care. 🎯#Brachytherapy boosts survival, helps preserve function & QoL, yet remains underused. 📢 Oncology professionals: ✅ Raise awareness ✅ Support access ✅ Empower patients 👉https://bit.ly/4lwRdTL

At #ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.” 💬 With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end. 👉 bit.ly/3Iavy59

Congratulations to our journal TipsRO - Technical Innovations and Patient Support in Radiation Oncology for achieving its first Impact Factor of 2.8! A reflection of the quality and dedication of the editorial team, authors, and the entire #RTT community.

A really educational day. Big shoutout to Tom Rackley & Rebecca Muirhead for leading the event & superstars @alison-tree.bsky.social and Dione Lother for sharing their wisdom. Amazing practical insights from @aileenduffton.bsky.social @marina-khan.bsky.social Helen Grimes & Joe Flaherty. Congrats!

We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social

Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology @alison-tree.bsky.social @harshanigreen.bsky.social Full-text link: authors.elsevier.com/a/1lFrI3lXQo...

"We’re very clear that research inclusion is essential—not political. If your research isn’t representative, it’s not going to improve outcomes across our population." Lucy Chappell, chief executive @nihr.bsky.social, explains why research inclusion is vital www.bmj.com/content/389/...

Are you an experienced #Biostatistician looking for the next step in your #ClinicalTrials career? We are recruiting for a research group leader to develop and grow our academic clinical trials portfolio. Find out more and apply here: #StatsJobs #ResearchJobs 🧪 jobs.icr.ac.uk/vacancies/12...

🧠📸 Proud to represent RTTs as part of the 2022 ESTRO Physics Workshop IGRT Working Group! Our expert consensus on optimising CBCT doses for IGRT is now available. 🔗 doi.org/10.1016/j.ra... #MedPhysics #Radiotherapy #IGRT #ESTRO2022 #MedicalImaging #RadiationOncology #RTT

Come and join us in Newcastle in November for all things #SABR at this years @uksabr.bsky.social #RTT #MedPhys #ClinOnc #Radiotherapy

📰 BREAKING: Researchers show that pembrolizumab, an immunotherapy drug, helps head and neck cancer patients live years longer cancer-free. The drug also hunts down cancer trying to spread. Results from the the phase III KEYNOTE-689 trial are presented at #ASCO25 ⤵️ www.icr.ac.uk/about-us/icr...

2x free passes for UKONS 2025 via Paxman Scalp Cooling Here’s how… 1. Submit a poster abstract by 13th June (ideally) with a focus on scalp cooling (alongside guidelines on UKONS website) to [email protected] 2. Two applicants are guaranteed delegate passes to the event. #UKONS

What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!

Last chance at #ESTRO25! From streamlining workflows to enabling maskless head & neck treatments, AlignRT delivers unmatched precision and efficiency in radiation therapy. Stop by booth 240 to see AlignRT in action.

Congratulations to EMBRACE Collaborative Group for Donal Hollywood Award! EMBRACE trials set the clinical standard for cervical cancer RT. #ESTRO25 #ESTRO2025

Congratulations Corinne on the @ESTRO_RT #BreurAward Do we have parity of women in leadership? NO #ESTRO25 @mcrcnews.bsky.social @uniofmanchester.bsky.social @mguckenberger.bsky.social

Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25

Congratulations to our formidable Professor Corinne Faivre-Finn! 🏆 #ESTRO25 #TeamManchester @uom-dcs.bsky.social @mcrcnews.bsky.social

Congratulations Liz on your interdisciplinary award👏🏽🥳 @rttqa.bsky.social _UK does an incredible job ensuring that #radiotherapy is robust. Fantastic leadership! @nhsengland.bsky.social #ESTRO25

Congratulations to Professor Faivre-Finn #BreurAward #ESTRO25. Fantastic and inspiring lecture. We still have much work to do to level the playing field.

Exciting things are happening in SGRT, and one you won’t want to miss is MapRT. Designed to support safer, more efficient non-coplanar treatments, MapRT helps you visualize and manage beam and couch positions in real-time. Visit booth 240 at #ESTRO25 for a live demo!

Congratulations to our very own Liz Miles, incredible colleague, mentor & friend on her #ESTRO25 Interdisciplinary Award. A true champion for #collaboration and #RTQA. So well deserved- we could not be prouder!

📢Day 3 - We hope you're still making the most of every moment! From insightful talks to inspiring connections, the energy is still going strong! See you tonight for the social event! don't forget to pick up your tickets at the registration desk! #ESTRO25 #Radiotherapy #Oncology

At hashtag#ESTRO25, Igor Bessières, Medical Physicist at Centre Georges-François Leclerc, presented how surface-guided planning can enhance treatment quality, serving as a tool for clearance prediction, beam optimization, and non-coplanar workflows.

@gerryhanna.bsky.social off to a strong start debating about the management of stage III NSCLC in the IO era: knife or beam. #ESTRO25

👏 What a night! The #ESTRO25 Opening Ceremony set the tone for a week of innovation and collaboration. Inspiring talks, a visionary keynote by Pascal Uffer, and Lifetime Achievement Awards for Heijmen, Marijnen & Favaudon. #RadiationOncology #ESTRO25

ESTRO Collaborates with OncoDaily in the Framework of ESTRO25 oncodaily.com/blog/oncodai... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO #ESTRO25

ESTRO25 Abstract Insights oncodaily.com/insight/estr... #Abstracts #Cancer #ESTRO #ESTRO25 #OncoDaily #Oncology #Medicine #Health

Really delighted and grateful to be elected to a professorial fellowship at @tcddublin.bsky.social Huge gratitude to my colleagues, collaborators and friends who have supported me over the years, but huge 🙏 to Suzie and my family ❤️ @leechmmichelle.bsky.social @qubelfastofficial.bsky.social

The Lancet has a forceful editorial out today on this leaked letter I shared below. Good on @richardhorton1. I'd like to see similar principled stands by US journal editors and other leaders of powerful US medical institutions. www.thelancet.com/journals/lan...

Impt paper from @npca-natcan.bsky.social-geographic variation in prostate cancer diagnosis bmjoncology.bmj.com/content/4/1/... Areas with the HIGHEST risk of metastatic disease have the LOWEST incidence of all prostate cancer. Prostate cancer is curable if caught early @prostatecanceruk.bsky.social